About MEDS
MEDS is a company based in Stockholm (Sweden) founded in 2017 by Bjorn Thorngren. MEDS has raised $26.34 million across 2 funding rounds from investors including M2 Asset Management AB and Inbox Capital. MEDS offers products and services including MEDS Online Platform, Prescription Management Service, and Beauty Product Catalog. MEDS operates in a competitive market with competitors including Apoteket, Apotek Hjrtat, Apotea, Apotekamo and Apohem, among others.
- Annual Revenue$109.67 M (USD)21.37as on Dec 31, 2025
- Net Profit$839.32 K (USD)0as on Dec 31, 2025
- EBITDA$667.77 K (USD)33.36as on Dec 31, 2025
- Total Equity Funding$26.34M (USD)
in 2 rounds
- Latest Funding Round$20.61M (USD), Series B
Jan 2021
- InvestorsM2 Asset Management AB
& 1 more
Products & Services of MEDS
MEDS offers a comprehensive portfolio of products and services, including MEDS Online Platform, Prescription Management Service, and Beauty Product Catalog.
Platform for ordering medications and health products online
Tool for handling and refilling prescriptions digitally
Collection of skincare and personal care items for purchase
Funding Insights of MEDS
MEDS has successfully raised a total of $26.34M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $20.61 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $26.34M
- Total Rounds 2
- Last Round Series B — $20.61M
- First Round $5.73M
(Jan 2019)
- Investors Count 2
All 2 funding rounds of MEDS with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | $20.61M | Series B | – | M2 Asset Management AB | – |
| Jan 2019 | $5.73M | Series A | – | Inbox Capital | – |
2 investors in total: 2 institutional.
Investors in MEDS
MEDS has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include M2 Asset Management AB and Inbox Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage tech-focused VC firm investing primarily in Sweden | – | inboxcap.com | Stockholm, Sweden | |
Invests in and manages real estate properties, develops assets, and handles financial reporting in Sweden. | 1999 | m2assetmanagement.se | Stockholm, Sweden |
Investor details for MEDS
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MEDS
26 people are tracked at MEDS (12 in leadership, 14 in team).
| Name | Role | Group |
|---|---|---|
Bjorn Thorngren | Co-Founder & CEO | Leadership |
Maria Tengblad | Art Director & Content Lead | Leadership |
Adham Shawwaf | COO | Leadership |
Vesam Ashouri | Inköp & Marknadschef / Purchasing & Marketing Director | Leadership |
Björn Thorngren | Founder and CEO | Leadership |
Sofia Söderqvist | Chief Commercial Officer (CCO) | Leadership |
Johan Norén | Head Of Information Technology | Leadership |
Philip Leijon | Head Of Finance | Leadership |
Nick Mendola | Chief Financial Officer | Leadership |
Nicklas Krus | Head of Performance | Leadership |
Sener Özel | Head of Logistics | Leadership |
Mathilda Berg | People & Culture Business Partner | Leadership |
CB Du Rietz | Systems Developer | Team |
Alexandra Käck | Kategorichef | Team |
Erik Cederblad | Developer | Team |
Jessika Tjärnberg | Customer Success Manager | Team |
Lisa Karlsson | Campaign Coordinator | Team |
Anna Bengtsson | Developer | Team |
Robert Ericsson | Senior System Developer | Team |
Christoffer Svan | Group financial controller | Team |
6 more people are available in the full profile.
Complete people profiles for MEDS
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of MEDS
MEDS is a publicly listed company on the OMXSTO with ticker symbol MEDS in Sweden. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date23 Sep 2025
- Listed onSTO: MEDS
- Listed entityMeds Apotek AB
- ISINSE0018014110
- Share price22.50 SEK (+2.27% on the day) · 2026-10-09
- Market capitalisation417,874,002.00 SEK
- Price to earnings29.2
- EPS (diluted, trailing year)0.77 SEK
- Volume (last session)49,771
Financials of MEDS
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 1.01B SEK | 7.7M SEK | 6.2M SEK |
| 2024 | 829.2M SEK | -10.4M SEK | 4.6M SEK |
| 2023 | 655.2M SEK | -51.0M SEK | -33.0M SEK |
| 2021 | 187.6M SEK | -44.8M SEK | -46.3M SEK |
| 2020 | 228.8M SEK | -86.3M SEK | -86.5M SEK |
Detailed financial statements for MEDS
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of MEDS
4 dated milestones of MEDS across 8 years, from founding to its latest funding, stage changes and deals.
- Founded MEDS is founded.
- Funding First funding round of $5.7M.
- Funding Latest funding round, Series B, of $20.6M.
- IPO Lists on the stock exchange (IPO).
Competitors of MEDS
MEDS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Apoteket, Apotek Hjrtat, Apotea, Apotekamo and Apohem, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| apoteket.se | 1970 | Solna, Sweden | – | – | Operates an online store for purchasing medicines and healthcare products. | |
| apotekhjartat.se | 2010 | Stockholm, Sweden | – | – | Pharmacy chain operated across Sweden with online retail services. | |
| apotea.se | 2011 | Stockholm, Sweden | – | – | Online pharmacy store | |
| apotekamo.com | 2018 | Stockholm, Sweden | $2.54M | – | Medicines and health products are offered online for home delivery. | |
| apohem.se | 2017 | Stockholm, Sweden | $2M | – | Online drug store | |
| sparrowhawk.se | 2022 | Stockholm, Sweden | – | – | Operates a digital platform for efficient delivery of medicines and test kits. | |
| njuablaapotek.com | 2020 | Alingsas, Sweden | – | – | Offers an online pharmacy for convenient access to medications. |
Detailed competitors of MEDS
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MEDS
The website of MEDS (meds.se) receives about 2M visits a month.
- Monthly visits2M
▲ 2% vs previous month
Websites whose visitors overlap most with MEDS. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| apohem.se | 100% | 2.8M | #19,799 | View details | |
| ahlens.se | 69% | 4.1M | #13,066 | View details | |
 amazon.se | amazon.se | 67% | – | #2,454 | – |
| cdon.se | 64% | 2.6M | #23,261 | View details | |
adlibris.com | adlibris.com | 61% | – | #9,460 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for MEDS
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Meds
Complete news archive for MEDS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to MEDS
10 companies that operate in the same segment as MEDS (Digital Health & Telemedicine), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of an online pharmacy with doctor listing and teleconsultation services | 2015 | Delhi, Delhi, India | USD 194 M | – | – | |
Online platform offering multiple healthcare services | 2013 | Bengaluru, Karnataka, India | USD 199.22 M | USD 62.4 M | 52 | |
An application is provided for comparing prescription drug prices nationwide. | 2011 | Santa Monica, California, United States | USD 22.21 M | USD 796.85 M | 738 | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 233 | |
An online marketplace for healthcare products is operated. | 2011 | Kolkata, West Bengal, India | USD 38.26 M | – | – | |
Alto Pharmacy is focused on providing convenient prescription delivery services. | 2015 | San Francisco, California, United States | USD 591.64 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – | |
Telehealth solutions are provided for doctors and patients' consultations. | 2006 | Boston, Massachusetts, United States | USD 887.35 M | USD 115.54 M | 742 | |
Digital health services for men's wellness are offered by Ro. | 2017 | New York, New York, United States | USD 1.03 B | – | 703 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MEDS
MEDS was founded in 2017 and raised its 1st funding round 2 years after it was founded.
MEDS is headquartered in Stockholm, Sweden.
Bjorn Thorngren is the current CEO of MEDS. They have also founded this company.
MEDS is a funded company, having raised a total of $26.34M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5.73M, raised on Jan 2019.
Annual revenue of MEDS is $109.67M as on Dec 31, 2025.
MEDS was founded in 2017 in Stockholm, Sweden, and operates as an online pharmacy in the healthcare sector. Prescription and over-the-counter medicines are offered, along with food supplements and products for categories such as fever and aches, skin care, intimate care, stomach and intestines. Cosmetics and beauty items are also included in the catalog, with services provided through the domain meds.se.
MEDS's top competitors include Apotek Hjrtat, Apotea and Apotekamo.
MEDS offers MEDS Online Platform, Prescription Management Service, and Beauty Product Catalog.
Yes, MEDS is publicly traded on OMXSTO under the ticker symbol MEDS.
MEDS has 2 investors. Key investors include M2 Asset Management AB, and Inbox Capital.
The website of MEDS receives about 2 million visits a month.